ليست عنوان مقالات لاتين Myasthenia gravis and coronavirus disease 2019: A report from Iran Myocardial perfusion imaging with technetium-99m sestamibi in patients with cocaine-associated chest Pain

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Myasthenia gravis and coronavirus disease 2019: A report from Iran

2

Myasthenia Gravis and COVID-19: A Systematic Review and Meta-analysis

3

Myasthenia gravis and levonorgestrel implant

4

Myasthenia Gravis and Related Disorders: H.J. Kaminski, The Human Press, 2002, ISBN 1-58829-058-1, price US$ 125.00 (hardback), 408 pages

5

Myasthenia gravis and scleroderma: Two cases and a review of the literature

6

MYASTHENIA GRAVIS AND SEVOFLURANE - A Case Report -

7

Myasthenia gravis as a presenting feature in a patient with lung cancer: A case report

8

MYASTHENIA GRAVIS ASSOCIATED WITH AUTOIMMUNE THYROID DISEASE: A REPORT OF TWO PATIENTS

9

Myasthenia gravis from Thomas Willis to the present

10

MYASTHENIA GRAVIS IN IRANIAN CHILDREN

11

Myasthenia gravis in Iranian children

12

Myasthenia gravis on the Dutch antilles: an epidemiological study

13

Myasthenia gravis presenting as a unilateral abducens nerve palsy

14

Myasthenia gravis with acute respiratory failure in the emergency department

15

Myasthenia gravis with autoimmune autonomic neuropathy

16

Myasthenia Gravis: A Comparisonof Clinical Presentation and Diagnostic Tests among different Gender Groups in Pakistani Population

17

Myasthenia gravis: an illustrated history: By John Keesey, MD, 2002, Roseville, California, Publishers Design Group, 120 pp, illustrated, $49.95, ISBN: 1-929170-04-1

18

Myasthenia gravis: recommendations for clinical research standards

19

Myasthenia gravis-associated systemic vasculitis and myocarditis with involvement of the cardiac conducting tissue

20

Myasthenic crisis after botulinum toxin

21

Myasthenic crisis presenting as isolated vocal cord paralysis

22

Myatt, G.J. (2007). Making sense of data: a practical guide to exploratory data analysis and data mining (pp. 280). Wiley.

23

MYB down-regulation enhances sensitivity of U937 myeloid leukemia cells to the histone deacetylase inhibitor LBH589 in vitro and in vivo

24

Myb protein specificity: evidence of a context-specific transcription factor code

25

MYB transcription factors in Arabidopsis

26

MYB transcription factors in Arabidopsis

27

MYB98 Is Required for Pollen Tube Guidance and Synergid Cell Differentiation in Arabidopsis

28

MYBBP1a is a Novel Repressor of NF-κB

29

MyBP-C phosphorylation in donor, failing and HOCM human heart muscle

30

Myc activation reduces fibroblast clonogenicity via an apoptotic mechanism that can be suppressed by a soluble paracrine factor

31

MYC amplification and TERT expression in breast tumor progression

32

MYC Amplification in Two Further Cases of Acute Myeloid Leukemia with Trisomy 4 and Double Minute Chromosomes

33

MYC gene amplification in double minute chromosomes in an aggressive large B-cell lymphoma with leukemic presentation: a case report

34

MYC genes with differential responses to tapping, mechanical wounding, ethrel and methyl jasmonate in laticifers of rubber tree (Hevea brasiliensis Muell. Arg.)

35

MYC in gastric carcinoma and intestinal metaplasia of young adults

36

MYC on the Path to Cancer

37

MYC Participates in Lipopolysaccharide-Induced Sepsis via Promoting Cell Proliferation and Inhibiting Apoptosis

38

MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells

39

Myc: A Weapon of Mass Destruction

40

Mycaloside A, a new steroid oligoglycoside with an unprecedented structure from the Caribbean sponge Mycale laxissima

41

Mycangial fungus benefits the development of a leaf-rolling weevil, Euops chinesis

42

Myc-driven murine prostate cancer shares molecular features with human prostate tumors

43

Myc-driven murine prostate cancer shares molecular features with human prostate tumors

44

Mycelia of Mucor rouxii as a source of chitin and chitosan

45

Mycelial Compatibility Grouping and Aggressiveness of Sclerotinia sclerotiorum on Different Hosts in North of Iran

46

Mycelial Compatibility Groupings and Pathogenic Diversity of Sclerotinia sclerotiorum (Lib.) de Bary Populations on Canola in Golestan Province of Iran

47

Mycelial compatibility groups in Sclerotium cepivorum

48

Mycelial compatibility reactions of Australian Fusarium graminearum and F. pseudograminearum isolates compared with AFLP groupings

49

Mycelial growth and exclusion of Heterobasidion parviporum inoculated in branches of 15-year-old Picea abies clones

50

Mycelial growth of Philippine mushroom Lentinus tigrinus in selected cucurbit-based media and its antioxidant activity

51

Mycelium differentiation and development of Streptomyces coelicolor in lab-scale bioreactors: Programmed cell death, differentiation, and lysis are closely linked to undecylprodigiosin and actinorhodin production

52

Mycelium growth and degradation of creosote-treated wood by basydiomycetes

53

Mycelium of arbuscular mycorrhizal fungi increases soil water repellency and is sufficient to maintain water-stable soil aggregates

54

Mycelium of arbuscular mycorrhizal fungi increases soil water repellency and is sufficient to maintain water-stable soil aggregates

55

Mycelium-bound carboxylesterase from Aspergillus oryzae: an efficient catalyst for acetylation in organic solvent

56

Mycenae and Tiryns: the Pottery of the Second Half of the Thirteenth Century BC - Contexts and Definitions

57

Mycenae Revisited Part 2. Exploring the Local versus Non-local Geographical Origin of the Individuals from Grave Circle A: Evidence from Strontium

58

Mycenae Revisited Part 3. The Human Remains from Grave Circle A at Mycenae. Behind the Masks: A Study of the Bones of Shaft Graves I–V

59

Mycetoglyphus qassimi and Tyrophagus putrescentiae, Two Acarid Mites Recovered from Palm Fields, Feeding on Root-Knot Nematode Meloidogyne javanica in Al-Qassim Area, Saudi Arabia

60

61

Mycetoma Caused by Acremonium Species ina Patient with Chronic Granulomatous Disease

62

Mycetoma revisited :Incidence of various radiographic signs

63

MYCETOMA: A LOCAL EXPERIENCE

64

Mycetoma: A report of 8 cases at tertiary care hospital in Central India with review of literature

65

Mycetozoal bloom in a hydroponic culture of garden cress (Lepidium sativum L.)

66

Mycielski approach for wind speed prediction

67

Myc—Is this the oncogene from Hell?

68

MYCN gain and MYCN amplification in a stage 4S neuroblastoma

69

MYCN Gene Copy Number Status Detected by FISH Method and Its Correlation with Outcome and Clinicopathological Variables in Childhood Neuroblastoma

70

MYCN in neuronal tumours

71

MYCN oncoprotein targets and their therapeutic potential

72

Myc-Nick: A Cytoplasmic Cleavage Product of Myc that Promotes α-Tubulin Acetylation and Cell Differentiation

73

MYCN-mediated overexpression of mitotic spindle regulatory genes and loss of p53-p21 function jointly support the survival of tetraploid neuroblastoma cells

74

Myco-agro sorbents: novel heavy metal sequesters

75

Mycobacteria - related to the aetiopathogenesis of primary biliary cirrhosis?

76

Mycobacteria - related to the aetiopathogenesis of primary biliary cirrhosis?

77

Mycobacteria and sarcoidosis

78

Mycobacteria in the environment of pig farms in the Czech Republic between 2003 and 2007

79

Mycobacteria in water, feedstocks and food: analysis of publications

80

Mycobacteria, but not mercury, induces metallothionein (MT) protein in striped bass, Morone saxitilis, phagocytes, while both stimuli induce MT in channel catfish, Ictalurus punctatus, phagocytes

81

Mycobacteria: Genetics of Resistance and Implications for Treatment

82

Mycobacterial ABC Transport System: Structure of the Primary Phosphate Receptor

83

Mycobacterial Antibodies Against BCG and M.Tuberculosis H37RA Do Not Recognize Pathogenic M.Tuberculosis Cells but Do Recognize Their Cytoplasmic Constituents

84

Mycobacterial Antibodies Against BCG and M.Tuberculosis H37RA Do Not Recognize Pathogenic M.Tuberculosis Cells but Do Recognize Their Cytoplasmic Constituents

85

Mycobacterial disease in renal allograft recipients

86

Mycobacterial disease: A historical and epidemiologic perspective

87

Mycobacterial DNA Gyrase: Enzyme Purification and Characterization of Supercoiling Activity

88

Mycobacterial DNA not detected in liver sections from patients with primary biliary cirrhosis

89

Mycobacterial formulation in liposomes showed decreased expression of CD95/CD95L and caspase activity in T cells of leprosy patients

90

Mycobacterial Gene Cloning and Expression, Comparative Genomics, Bioinformatics and Proteomics in Relation to the Development of New Vaccines and Diagnostic Reagents

91

Mycobacterial granulomas: keys to a long-lasting host–pathogen relationship

92

Mycobacterial HSP70 as an adjuvant in the design of an idiotype vaccine against a murine lymphoma

93

Mycobacterial infection and the impact of rifabutin treatment in organ transplant recipients: a single-center study

94

Mycobacterial infections in multiple species: Implications for diagnosis and control

95

Mycobacterial Phenolic Glycolipid Virulence Factor Biosynthesis: Mechanism and Small-Molecule Inhibition of Polyketide Chain Initiation Original Research Article

96

Mycobacterial protein boosts BCG immunity

97

Mycobacteriosis in fishes: A review

98

MYCOBACTERIUM ULCERANS INFECTION (BURULI ULCER): FIRST REPORTED CASE IN A TRAVELER

99

Mycobacterium abscessus in a long-term respiratory care unit

100

Mycobacterium arupense among the isolates of non-tuberculous mycobacteria from human, animal and environmental samples

101

Mycobacterium Avium and Mycobacterium intracellulare Infections in Slaughtered Pigs in Makurdi, North-Central Nigeria: An Emerging Zoonosis

102

Mycobacterium avium Complex Extracellular Vesicles Attenuate Inflammation via Inducing IL-10

103

Mycobacterium avium subsp. avium in domestic pigeons (Columba livia f. domestica) diagnosed by direct conventional multiplex PCR: a case report

104

Mycobacterium avium subsp. Paratuberculosis in a mouflon herd without clinical symptoms monitored using IS900 real-time PCR: a case report

105

Mycobacterium avium subsp. paratuberculosis in muscle, lymphatic and organ tissues from cows with advanced Johneʹs disease

106

Mycobacterium avium subsp. paratuberculosis induces differential cytosine methylation at miR-21 transcription start site region

107

Mycobacterium avium subsp. paratuberculosis survival during fermentation of soured milk products detected by culture and quantitative real time PCR methods

108

Mycobacterium avium subspecies paratuberculosis bacteraemia in patients with inflammatory bowel disease

109

Mycobacterium Avium Subspecies Paratuberculosis Multibacillary Infection (Johne’s disease) ina Teddy Goat

110

Mycobacterium avium subspecies paratuberculosis suppresses expression of IL-12p40 and iNOS genes induced by signalling through CD40 in bovine monocyte-derived macrophages

111

Mycobacterium avium subspecies paratuberculosis suppresses expression of IL-12p40 and iNOS genes induced by signalling through CD40 in bovine monocyte-derived macrophages

112

Mycobacterium avium subspecies paratuberculosis: A possible causative agent in human morbidity and risk to public health safety

113

Mycobacterium avium subspecies paratuberculosis: the nature of the problem

114

Mycobacterium avium subspecies paratuberculosisA Review of Present Research in Norway

115

Mycobacterium aviumComplex Activates Nuclear Factor κB via Induction of Inflammatory Cytokines

116

Mycobacterium aviumReduces Expression of Costimulatory/Adhesion Molecules by Human Monocytes

117

Mycobacterium bovis AN5 antigens vary in their ability to induce nitric oxide production in blood monocytes of experimentally infected cattle

118

Mycobacterium bovis AN5 antigens vary in their ability to induce nitric oxide production in blood monocytes of experimentally infected cattle

119

Mycobacterium bovis Bacillus Calmette-Guérin (BCG) stimulates human β-defensin-2 gene transcription in human epithelial cells

120

Mycobacterium bovis Bacillus Calmette–Guérin (BCG) stimulates IL-10 production via the PI3K/Akt and p38 MAPK pathways in human lung epithelial cells

121

Mycobacterium bovis Bacillus Calmette-Guérin (BCG)-induced activation of PI3K/Akt and NF-kB signaling pathways regulates expression of CXCL10 in epithelial cells

122

Mycobacterium bovis bacillus Calmette–Guérin (BCG)-induced CXCL8 production is mediated through PKCα-dependent activation of the IKKαβ signaling pathway in epithelial cells

123

Mycobacterium bovis BCG decreases MHC-II expression in vivo on murine lung macrophages and dendritic cells during aerosol infection

124

Mycobacterium bovis BCG induces CXC chemokine ligand 8 secretion via the MEK-dependent signal pathway in human epithelial cells

125

Mycobacterium bovis BCG Toll-Like Receptors 2 and 4 Cooperation Increases the Innate Epithelial Immune Response

126

Mycobacterium bovis BCG vaccine induces non-specific immune responses in Japanese flounder against Nocardia seriolae

127

Mycobacterium bovis in Korea: An update

128

Mycobacterium bovis infection in badger cubs: Re-assessing the evidence for maternally derived immunological protection from advanced disease

129

Mycobacterium bovis infection in badger cubs: Re-assessing the evidence for maternally derived immunological protection from advanced disease

130

Mycobacterium bovis infection in domestic pigs in Great Britain

131

Mycobacterium bovis infection: Everything but the cow

132

Mycobacterium bovis infections in domesticated non-bovine mammalian species. Part 1: Review of epidemiology and laboratory submissions in Great Britain 2004–2010

133

Mycobacterium bovis infections in domesticated non-bovine mammalian species. Part 2: A review of diagnostic methods

134

Mycobacterium bovis tuberculins: Preparation and antigenic properties

135

Mycobacterium bovis tuberculosis: forgotten, but not gone

136

Mycobacterium bovis vertebral osteomyelitis as a complication of intravesical administration of bacille Calmette-Guérin

137

Mycobacterium bovis: guidance on BCG vaccination is needed

138

Mycobacterium boviss Infection and Tuberculosis in Cattle

139

Mycobacterium chelonae interface infection after endokeratoplaty

140

Mycobacterium chelonae keratiti after laer in itu keratomileui uccefully treated with medical therapy and flap removal

141

Mycobacterium chelonae Keratitis Following Laser in situ Keratomileusis (LASIK) Specifically Identified by INNO-LIPA Method

142

Mycobacterium fortuitum prosthetic valve endocarditis: a case for the pathogenetic role of biofilms

143

Mycobacterium fortuitum-induced surgical wound infection - a case report

144

Mycobacterium gordonae in fiberoptic bronchoscopes

145

Mycobacterium leprae-induced demyelination: a model for early nerve degeneration

146

Mycobacterium marinum

147

Mycobacterium marinum as a cause of skin chronic granulomatous in the hand

148

Mycobacterium marinum hand infection: case reports and review of literature

149

Mycobacterium Marinum Infection after Infliximab Therapy

150

Mycobacterium marinum infection: A case report

151

Mycobacterium mucogenicum and Klebsiella pneumoniae Pulmonary Infection in a Patient Following Cardiac Surgery: A Case Report

152

Mycobacterium mucogenicum causing central line-related sepsis in a home parenteral nutrition patient

153

Mycobacterium mucogenicum meningitis due to external ventricular drain

154

Mycobacterium paratuberculosis and Milk

155

Mycobacterium paratuberculosis heat shock protein 70 as a tool in control of paratuberculosis

156

Mycobacterium paratuberculosis heat shock protein 70 as a tool in control of paratuberculosis

157

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

158

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

159

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

160

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

161

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

162

Mycobacterium paratuberculosis suppresses CD40 signaling induced IL-12p40 and iNOS gene expression in bovine monocyte-derived macrophages

163

Mycobacterium simiae Isolates Subtypes and Molecular Drug Susceptibility in Iran

164

Mycobacterium Strain and Type of Resistance in Pulmonary Tuberculosis Patients: A Missed Link in Iran’s National Tuberculosis Plan

165

Mycobacterium Thermoresistibile Infection in a Child

166

Mycobacterium tuberculosis alters the differentiation of monocytes into macrophages in vitro

167

Mycobacterium tuberculosis and bovis as causes for shrinking bladder

168

Mycobacterium tuberculosis and Cryptococcus neoformans co-infection meningitis in a young immuncompetent woman

169

Mycobacterium tuberculosis and Dual M. tuberculosis/M. bovis Infection as the Cause of Tuberculosis in a Gorilla and a Lioness, Respectively, in Ibadan Zoo, Nigeria

170

Mycobacterium tuberculosis and lipids: Insights into molecular mechanisms from persistence to virulence

171

Mycobacterium tuberculosis and non-tubercular mycobacterium infection in women with unexplained infertility from eastern India

172

Mycobacterium tuberculosis and non-tubercular mycobacterium infection in women with unexplained infertility from eastern India

173

Mycobacterium tuberculosis and pemphigus vulgaris

174

Mycobacterium Tuberculosis Breast Infection Mimicking Pyogenic Abscesses in Kuwait

175

Mycobacterium tuberculosis Detection based on mpt64 amplification by Nested-PCR in Sputum samples

176

Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso

177

Mycobacterium tuberculosis genome sequence illuminates bugʹs biology

178

Mycobacterium tuberculosis GroEL Homologues Unusually Exist as Lower Oligomers and Retain the Ability to Suppress Aggregation of Substrate Proteins

179

Mycobacterium tuberculosis H37Rv3377c encodes the diterpene cyclase for producing the halimane skeleton

180

Mycobacterium tuberculosis heat shock proteins and autoimmunity in sarcoidosis

181

Mycobacterium tuberculosis Hsp16.3 Nonamers are Assembled and Re-assembled via Trimer and Hexamer Intermediates

182

Mycobacterium tuberculosis HspX/EsxS Fusion Protein: Gene Cloning, Protein Expression, and Purification in Escherichia coli

183

Mycobacterium tuberculosis infection and FHIT gene alterations in lung cancer

184

Mycobacterium tuberculosis infection in grazing cattle in central Ethiopia

185

Mycobacterium tuberculosis infection in travellers: tuberculosis comes home

186

Mycobacterium tuberculosis infection in women with unexplained infertility

187

Mycobacterium tuberculosis infection presenting with cutaneous abscess and osteomyelitis

188

Mycobacterium Tuberculosis Infection: Participation of TH1, TH2, TH17 and Regulatory T Cells in the Immune Response

189

Mycobacterium tuberculosis Inhibits MHC Class II Antigen Processing in Murine Bone Marrow Macrophages

190

Mycobacterium tuberculosis ManLAM inhibits T-cell-receptor signaling by interference with ZAP-70, Lck and LAT phosphorylation

191

Mycobacterium tuberculosis Protein Tyrosine Phosphatase PtpB Structure Reveals a Diverged Fold and a Buried Active Site

192

Mycobacterium tuberculosis Ribose-5-phosphate Isomerase has a Known Fold, but a Novel Active Site

193

Mycobacterium tuberculosis spoligotypes circulating in the Lebanese population: a retrospective study

194

Mycobacterium tuberculosis Thymidylate Kinase: Structural Studies of Intermediates along the Reaction Pathway

195

Mycobacterium tuberculosis transmission and HIV status

196

Mycobacterium tuberculosis transmission and HIV status

197

Mycobacterium tuberculosis transmission and HIV status

198

Mycobacterium tuberculosis β-ketoacyl-ACP reductase: α-Secondary kinetic isotope effects and kinetic and equilibrium mechanisms of substrate binding

199

Mycobacterium tuberculosis: a stowaway in the cell

200

Mycobacterium tuberculosisComplex DNA in Ancient Human Bones

201

Mycobacterium ulcerans

202

Mycobacterium ulcerans disease (Buruli ulcer) following human bite

203

Mycobacterium ulcerans infection Review Article

204

Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial

205

Mycobacterium xenopi spinal infections after discovertebral surgery: investigation and screening of a large outbreak

206

Mycobial enhancement of ergothioneine by submerged cultivation of edible mushroom mycelia and its application as an antioxidative compound

207

Mycobiota and aflatoxin B1 contamination of Piper guineense (Ashanti pepper), P. nigrum L. (black pepper) and Monodora myristica (calabash nutmeg) from Lagos, Nigeria

208

Mycobiota and aflatoxin B1 contamination of rainbow trout(Oncorhinchus mykiss) feed with emphasis toAspergillus section Flavi

209

Mycobiota and co-occurrence of mycotoxins in Capsicum powder

210

Mycobiota and identification of aflatoxin gene cluster in marketed spices in West Africa

211

Mycobiota and mycotoxin contamination of maize flours and popcorn kernels for human consumption commercialized in Spain Original Research Article

212

Mycobiota and mycotoxin producing fungi from cocoa beans

213

Mycobiota and mycotoxins in Brazil nut samples from different states of the Brazilian Amazon region

214

Mycobiota and mycotoxins in Brazilian peanut kernels from sowing to harvest

215

Mycobiota and mycotoxins present in finished fish feeds from farms in the Rio de Janeiro State, Brazil

216

Mycobiota and natural occurrence of aflatoxin, deoxynivalenol, nivalenol and zearalenone in rice freshly harvested in South Korea

217

Mycobiota and Toxigenecity Profile of Aspergillus flavus Recovered from Food and Poultry Feed Mixtures in Cameroon

218

Mycobiota associated with larval mines of Thrypticus truncatus and T. sagittatus (Diptera, Dolichopodidae) on waterhyacinth, Eichhornia crassipes, in Argentina

219

Mycobiota Associated with Sugarcane (Saccharum officinarum L.) Cultivars in Iraq.

220

Mycobiota Associated with Sugarcane (Saccharum officinarum L.) Cultivars in Iraq.

221

Mycobiota in the processing areas of two different meat products

222

Mycobiota of cocoa: From farm to chocolate Original Research Article

223

Mycobiota of the arid Middle East: check-list of novel fungal taxa introduced from 1940 to 2000 and major recent biodiversity titles

224

Mycocutaneous atypical mycobacterial infections in acquired immunodeficiency syndrome

225

Mycoediketopiperazine, a novel fungal metabolite from a Papularia sp.

226

Mycoflora and absence of aflatoxin contamination of commercialized cassava chips in Benin, West Africa

227

Mycoflora and mycotoxins in field samples of Brazil nuts

228

Mycoflora and natural occurrence of aflatoxins and fumonisin B1 in cassava and yam chips from Benin, West Africa

229

Mycoflora and nutritional components of cocoa powder samples in South West Nigeria

230

Mycoflora and occurrence of aflatoxin in dried vegetables in Benin, Mali and Togo, West Africa

231

Mycoflora and ochratoxin A producing strains of Aspergillus in Algerian wheat

232

Mycoflora and Water Quality index Assessment of Water Sources in Oproama, Niger Delta, Nigeria

233

Mycoflora associated with cucurbits

234

Mycoflora Associated with Some Textiles in Jeddah City

235

Mycoflora associated with stored seeds of soybean

236

Mycoflora associated with tomato during the process of marketing

237

Mycoflora of Fungal Contamination in Wheat Storage (Silos) in Golestan Province, North of Iran

238

Mycoflora of Fungal Contamination in Wheat Storage (Silos) in Golestan Province, North of Iran

239

Mycoflora of human external auditory canal in Shiraz, southern Iran

240

Mycoflora of Ostrich (Struthio camelus) gastrointestinal tract as a human hazard

241

Mycoflora of paddy and milled rice produced in the region of Northeastern Argentina and Southern Paraguay

242

Mycoflora of pistachio and peanut kernels from Sari, Iran

243

Mycoflora of pistachio and peanut kernels from Sari, Iran

244

Mycoflora of the Interdigital Spaces Among Girl Students in Ahvaz, Iran

245

Mycogenesis of cerium oxide nanoparticles using Aspergillus niger culture filtrate and their applications for antibacterial and larvicidal activities

246

Mycogenesis of silver nanoparticles by different Aspergillus species

247

Mycogenic nanoparticles and their bio‑prospective applications: current status and future challenges

248

Myco-heterotroph/epiparasitic plant interactions with ectomycorrhizal and arbuscular mycorrhizal fungi

249

Mycohydrometallurgy: Biotransformation of double refractory gold ores by the fungus, Phanerochaete chrysosporium

250

Myco-hydrometallurgy: Coal model for potential reduction of preg-robbing capacity of carbonaceous gold ores using the fungus, Phanerochaete chrysosporium

251

Mycoinsecticides and Mycoacaricides: A comprehensive list with worldwide coverage and international classification of formulation types

252

Mycolactones and Mycobacterium ulcerans disease

253

Mycolic Acid Cyclopropanation is Essential for Viability, Drug Resistance, and Cell Wall Integrity of Mycobacterium tuberculosis Original Research Article

254

Mycolic Acids Constitute a Scaffold for Mycobacterial Lipid Antigens Stimulating CD1-Restricted T Cells Original Research Article

255

Mycological and histopathological findings of experimental disseminated candidiasis in dogs

256

Mycological aspects of onychomycosis in Khuzestan Province, Iran: A shift from dermatophytes towards yeasts

257

Mycological assessment of sediments in Ligurian beaches in the Northwestern Mediterranean: Pathogens and opportunistic pathogens

258

Mycological Evaluation of Imported Frozen Fish

259

Mycological evaluation of the phylloplane of Vigna unguiculata (L.) Walp

260

Mycological Identification of Some Fungi Isolated from Meat Products and Spices with Molecular Identification of Some Penicillium Isolates

261

Mycological investigation in patients with acute otitis media

262

Mycological Microscopic and Culture Examination of 400 Bronchoalveolar Lavage (BAL) Samples

263

Mycological quality and mycotoxin contamination of Sri Lankan peppers (Piper nigrum L.) and subsequent exposure assessment

264

Mycological Study of Superficial-cutaneous Mycoses in Tehran, Iran

265

Mycological Survey and Total Aflatoxin Analyze in Silage from Qaemshahr City (Northern Iran)

266

Mycological survey of ripped service tree fruits (Sorbus domestica L.) with an emphasis on toxinogenic fungi

267

Mycoparasitism of Ampelomyces quisqualis Ces. ex Schlecht on Powdery Mildew Fungi in Syria

268

Mycoparasitism of Pythium ultimum by Antagonistic Binucleate Rhizoctonia Isolates in Agar Media and on Capsicum Seeds

269

Mycoparasitism of Rhizoctonia solani by Endophytic Chaetomium spirale ND35: Ultrastructure and Cytochemistry of the Interaction

270

Mycophenolate mofetil

271

Mycophenolate mofetil - a new treatment for autoimmune hepatitis?

272

Mycophenolate Mofetil (MMF) Efficacy in Glomerulonephritis (GN), a Retrospective Analysis

273

Mycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil-induced gastrointestinal disorders

274

Mycophenolate Mofetil Ameliorates Perivascular T Lymphocyte Inflammation and Reduces the Double-Negative T Cell Population in SLE-Prone MRLlpr/lpr Mice

275

Mycophenolate mofetil and cyclosporin treatment for recalcitrant pyoderma gangrenosum

276

Mycophenolate mofetil associated with progressive multifocal leukoencephalopathy with successful outcome

277

Mycophenolate Mofetil Decreases Atherosclerotic Lesion Size by Depression of Aortic T-Lymphocyte and Interleukin-17–Mediated Macrophage Accumulation

278

Mycophenolate mofetil for Crohnʹs disease?

279

Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine

280

Mycophenolate Mofetil for Obliterative Bronchiolitis Syndrome After Lung Transplantation

281

Mycophenolate mofetil for prevention of acute rejection

282

Mycophenolate mofetil for severe autoimmune haemolytic anemia

283

Mycophenolate mofetil for systemic vasculitis and IgA nephropathy

284

Mycophenolate Mofetil for the Treatment of Uveiti Original Reearch Article

285

Mycophenolate mofetil for transplantation: new drug, old problems?

286

Mycophenolate Mofetil for Treatment of Idiopathic Nephrotic Syndrome in Children

287

Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome

288

Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: a preliminary study

289

Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C

290

Mycophenolate mofetil in Crohnʹs disease

291

Mycophenolate mofetil in IBD patients

292

Mycophenolate Mofetil in Low Doses Stabilizes and Improves Antineutrophil Cytoplasmic Antibody-associated Vasculitis and Lupus Nephritis

293

Mycophenolate mofetil in stem cell transplant patients in relation to plasma level of active metabolite

294

Mycophenolate mofetil monotherapy in liver transplantation

295

Mycophenolate mofetil prevents the development of experimental autoimmune myocarditis

296

Mycophenolate mofetil to rescue children with acute renal transplant rejection

297

Mycophenolate mofetil treatment reduces cholesterol-induced atherosclerosis in the rabbit

298

Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial

299

Mycophenolate mofetil versus cyclophosphamide for therapy of lupus nephritis: an evidence-based case report from systematic reviews and metaanalyses

300

Mycophenolate Mofetil versus Cyclosporine in Children with Frequent Relapse Nephrotic Syndrome

301

Mycophenolate mofetil: a new therapeutic option in dermatology

302

Mycophenolate mofetil: What is its place in the treatment of autoimmune rheumatic diseases?

303

Mycophenolate Mofetil; A Review of Indications and Use in a Large Tertiary Hospital

304

Mycophenolate sodium increases cyclosporine blood levels in renal transplant recipients

305

Mycophenolate Sodium versus Mycophenolate Mofetil: A Review of Their Comparative Features

306

Mycophenolic acid analogs with a modified metabolic profile Original Research Article

307

Mycophenolic acid as a latent agonist of PPARγ

308

Mycophenolic Acid Concentration on Vietnamese Renal Transplant Recipients

309

Mycophenolic Acid Influences T Helper 2 (Th2) Cytokine Induced Expression of Intercellular Cell Adhesion Molecule-1 (ICAM-1) on Human Endothelial Cells

310

Mycophenolic acid inhibits inosine 5′-monophosphate dehydrogenase and suppresses production of pro-inflammatory cytokines, nitric oxide, and LDH in macrophages

311

Mycophenolic acid-induced replication arrest, differentiation markers and cell death of androgen-independent prostate cancer cells DU145

312

Mycophenolic mofetil reduces the HLA antibody response of children to valved allograft implantation

313

Mycoplasma bovis and otitis in dairy calves in the United Kingdom

314

Mycoplasma bovis Infection with Enzootic Pneumonia Symptoms in a Beef Cattle Farm

315

Mycoplasma bovis-associated disease: Here, there and everywhere

316

Mycoplasma capricolum subsp. capripneumoniae, the cause of contagious caprine pleuropneumonia, comprises two distinct biochemical groups

317

Mycoplasma fermentans in joints of patients with rheumatoid arthritis and other joint disorders

318

Mycoplasma genitalium and Mycoplasma hominis infection in south Korea during 2018-2020

319

Mycoplasma hominis and Ureaplasma urealyticum in midtrimester amniotic fluid: Association with amniotic fluid cytokine levels and pregnancy outcome

320

Mycoplasma hominis infections occurring in cardiovascular surgical patients

321

Mycoplasma hominis parasitism of Trichomonas vaginalis

322

Mycoplasma hominis parasitism of Trichomonas vaginalis

323

Mycoplasma hominis parasitism of Trichomonas vaginalis

324

Mycoplasma host specificity: Fact or fiction?

325

Mycoplasma hyopneumoniae-derived lipid-associated membrane proteins induce apoptosis in porcine alveolar macrophage via increasing nitric oxide production, oxidative stress, and caspase-3 activation

326

Mycoplasma hyopneumoniae-derived lipid-associated membrane proteins induce apoptosis in porcine alveolar macrophage via increasing nitric oxide production, oxidative stress, and caspase-3 activation

327

Mycoplasma hyorhinis induces epithelial-mesenchymal transition in gastric cancer cell MGC803 via TLR4-NF-κB signaling

328

Mycoplasma hyorhinis infection of pigs selectively bred for high and low immune response

329

Mycoplasma hyorhinis infection of pigs selectively bred for high and low immune response

330

Mycoplasma Infection in Pyospermic Infertile and Healthy Fertile Men

331

Mycoplasma Infection in the Lungs of Cattle: The First Identification of Mycoplasma dispar in Iran

332

Mycoplasma ovipneumoniae induces inflammatory response in sheep airway epithelial cells via a MyD88-dependent TLR signaling pathway

333

Mycoplasma ovipneumoniae induces inflammatory response in sheep airway epithelial cells via a MyD88-dependent TLR signaling pathway

334

Mycoplasma pneumonia and Chlamydia pneumonia infection in patients admitted to Beheshti Hospital in Kashan with community-acquired pneumonia

335

Mycoplasma pneumonia in Cerebrospinal Fluids of Febrile Children With Neurologic Manifestations: A Cross Sectional Study, Tehran, Iran

336

Mycoplasma pneumonia infection and asthma: A clinical study

337

Mycoplasma pneumoniae and Recurrent Respiratory Tract Infection Within One Year After Treatment in Infants: Risk Factors and Prevalence

338

Mycoplasma pneumoniae causing nervous system lesion and SIADH in the absence of pneumonia

339

Mycoplasma pneumoniae co-infection with SARS-CoV-2: A case report

340

Mycoplasma pneumoniae community-acquired pneumonia (CAP) in the elderly: Diagnostic significance of acute thrombocytosis

341

Mycoplasma pneumoniae Infection Among Children: A Systematic Review and Meta-analysis of Published Literature

342

Mycoplasma Pneumoniae Infection with Neurologic Complications

343

Mycoplasma pneumoniae pneumonia following assisted ventilation

344

Mycoplasma pneumoniae preceding Lemierre’s syndrome due to Fusobacterium nucleatum complicated by acute Epstein–Barr virus (EBV) infectious mononucleosis in an immunocompetent host

345

Mycoplasma Synoviae and other Associated Bacteria Causing Arthritis in Chicken

346

Mycoplasma wenyonii: A Causative Agent of New Mastitis in Dairy Cows

347

Mycoplasma-like organisms in Hodgkinʹs disease

348

Mycoplasma-pneumoniae-Induced Thrombotic Thrombocytopenic Purpura

349

Mycoplasmas – Identifying hosts for a stealth pathogen

350

Mycoplasmas and oncogenesis

351

Mycoplasmas and Their Antibiotic Resistance: The Problems and Prospects in Controlling Infections

352

Mycoplasmoses of ruminants in France: recent data from the national surveillance network

353

Mycoplasmosis in Slaughtered She-Camels: Pathological Studies

354

Mycoprotein Production from Date Waste Using Fusarium venenatum in a Submerged Culture

355

Myco-remediation of Dairy Wastewater by Naturally Attenuated Aspergillus sp. Responsible for Sulfate Reduction

356

Mycoremediation of Dichlorvos Pesticide Contaminated Soil by Pleurotus pulmonarius (Fries) Quelet

357

Mycorrhiza between Kobresia bellardii (All.) Degel and Terfezia boudieri Chatin

358

Mycorrhiza formation is not needed for early growth induction and growth-related changes in polyamines in Scots pine seedlings in vitro

359

Mycorrhizae activity and diversity in conventional and organic apple orchards from Brazil

360

Mycorrhizae activity and diversity in conventional and organic apple orchards from Brazil

361

Mycorrhizae confer aluminum resistance to tulip-poplar seedlings

362

Mycorrhizae support oaks growing in a phylogenetically distant neighbourhood

363

Mycorrhizae support oaks growing in a phylogenetically distant neighbourhood

364

Mycorrhiza-induced resistance against the root–knot nematode Meloidogyne incognita involves priming of defense gene responses in tomato

365

Mycorrhiza-induced resistance against the root–knot nematode Meloidogyne incognita involves priming of defense gene responses in tomato

366

Mycorrhiza-induced resistance in banana acts on nematode host location and penetration

367

Mycorrhiza-induced resistance in banana acts on nematode host location and penetration

368

Mycorrhiza-induced resistance: more than the sum of its parts?

369

Mycorrhiza-induced resistance: more than the sum of its parts?

370

Mycorrhizal alleviation of acid soil stress in the sweet potato (Ipomoea batatas)

371

Mycorrhizal alleviation of acid soil stress in the sweet potato (Ipomoea batatas)

372

MYCORRHIZAL ASSOCIATION IN SOME WEEDS OF curcuma longa FIELDS OF DISTRICT KASUR, PAKISTAN

373

Mycorrhizal association of maritime pine, Pinus pinaster, with Rhizopogon roseolus has contrasting effects on the uptake from soil and root-to-shoot transfer of 137Cs, 85Sr and 95mTc

374

Mycorrhizal colonisation improves fruit yield and water use efficiency in watermelon (Citrullus lanatus Thunb.) grown under well-watered and waterstressed conditions

375

Mycorrhizal colonization and nitrogen uptake by maize: combined effect of tropical earthworms and velvetbean mulch

376

Mycorrhizal colonization of major banana genotypes in six East African environments

377

Mycorrhizal colonization with Glomus intraradices and development stage of transformed tomato roots significantly modify the chemotactic response of zoospores of the pathogen Phytophthora nicotianae

378

Mycorrhizal colonization with Glomus intraradices and development stage of transformed tomato roots significantly modify the chemotactic response of zoospores of the pathogen Phytophthora nicotianae

379

Mycorrhizal communities in relation to biomass production and nutrient use efficiency in two varieties of Douglas fir (Pseudotsuga menziesii var. menziesii and var. glauca) in different forest soils

380

Mycorrhizal communities in relation to biomass production and nutrient use efficiency in two varieties of Douglas fir (Pseudotsuga menziesii var. menziesii and var. glauca) in different forest soils

381

Mycorrhizal dependency of Chihuahuan Desert plants is influenced by life history strategy and root morphology

382

Mycorrhizal effects on nutrient cycling, nutrient leaching and N2O production in experimental grassland

383

Mycorrhizal effects on nutrient cycling, nutrient leaching and N2O production in experimental grassland

384

Mycorrhizal evolution

385

Mycorrhizal fungi biodiversity in Canadian soils

386

Mycorrhizal fungi enhance accumulation and tolerance of chromium in sunflower (Helianthus annuus)

387

Mycorrhizal fungi increase biocontrol potential of Pseudomonas fluorescens

388

Mycorrhizal fungi increase biocontrol potential of Pseudomonas fluorescens

389

MYCORRHIZAL FUNGUS (GLOMUS MOSSAE) INOCULATION EFFECTS ON PERFORMANCE AND ROOT BIOMASS DEVELOPMENT OF CACAO SEEDLINGS IN THE NURSERY

390

Mycorrhizal impact on osmotic adjustment in Ocimum basilicum during a lethal drying episode

391

Mycorrhizal networks: des liaisons dangereuses?

392

Mycorrhizal phosphorus enhancement of plants in undisturbed soil differs from phosphorus uptake stimulation by arbuscular mycorrhizae over non-mycorrhizal controls

393

Mycorrhizal protection of chili plants challenged by Phytophthora capsici

394

Mycorrhizal symbiosis and response of sorghum plants to combined drought and salinity stresses

395

Mycorrhizal symbiosis effects on growth of chalk false-brome (Brachypodium pinnatum) are dependent on the environmental light regime

396

Mycorrhizas and tropical soil fertility

397

MYCORRHIZATION AND USE OF SUPERABSORBENT POLYMERS IN TARGETED PRODUCTION OF HARDWOODS PLANTING MATERIAL

398

Mycorrhization of fossil and living plants

399

Mycorrhization of the notabilis and sitiens tomato mutants in relation to abscisic acid and ethylene contents

400

Mycosis fungoides and alopecia areata: A case report

401

Mycosis fungoides and Sézary syndrome

402

Mycosis fungoides during the COVID-19 pandemic: a teledermatology study

403

Mycosis Fungoides of the True Vocal Cord: A Case Report and Review of the Literature

404

Mycosis Fungoides Skin Wound Management With Skin Graft Post Ultraviolet Radiation therapy

405

Mycosis fungoides with an unusual clinicopathological presentation

406

Mycosphaerella graminicola produces a range of cell wall-degrading enzyme activities in vitro that vary with the carbon source

407

Mycosphaerella species associated with leaf disease of Eucalyptus globulus in Ethiopia

408

Mycosphaerella species occurring on Eucalyptus globulus and Eucalyptus nitens plantations of Tasmania, Australia

409

Mycosporine-like amino acid composition of the edible red alga, Palmaria palmata (dulse) harvested from the west and east coasts of Grand Manan Island, New Brunswick

410

Mycosporine-like amino acids (MAAs) protect against UV-B-induced damage in Gyrodinium dorsum Kofoid

411

Mycosporine-like amino acids in the marine dinoflagellate Gyrodinium dorsum: induction by ultraviolet irradiation

412

Mycosporine-like amino acids in the marine red alga Gracilaria cornea - effects of UV and heat

413

Mycosynthesis and characterization of selenium nanoparticles using standard penicillium chrysogenum PTCC 5031 and their antibacterial activity: A novel approach in microbial nanotechnology

414

Mycosynthesis of Silver Nanoparticles by Candida albicans Yeast and its Biological Applications

415

Mycosynthesis: Antibacterial, antioxidant and antiproliferative activities of silver nanoparticles synthesized from Inonotus obliquus (Chaga mushroom) extract

416

Mycotic Aneurysm of External Carotid Artery following Traumatic Brain Injury: Case Report and Review of Literature

417

Mycotic aneurysm of superior mesenteric artery branch presenting as pulsatile abdominal mass

418

Mycotic aneurysm of the aorta: Evolving surgical concept

419

Mycotic Aneurysm of the Descending Thoracic Aorta in a 2-kg Neonate

420

Mycotic Aneurysm of the Left Coronary Artery

421

Mycotic aneurysm of the left main coronary artery producing acute coronary occlusion and purulent pericarditis

422

Mycotic Aneurysm of the Thoracic Aorta Caused by Clostridium septicum

423

Mycotic aneurysm presenting as Pancoastʹs syndrome in an injection drug user

424

Mycotic aneurysm: A diagnostic challenge

425

Mycotic aneurysms of the abdominal aorta

426

Mycotic aneurysms of the thoracic aorta: a diagnostic challenge

427

Mycotic aortic aneurysm as a postsurgical complication: report of a case and review of the literature

428

Mycotic Aortic Aneurysm: Review of the Literature and Report of Two Cases

429

Mycotic Aortocoronary Saphenous Vein Graft Aneurysm Presenting With Unstable Angina Pectoris

430

Mycotic arch aneurysm and aortoesophageal fistula in a patient with melioidosis

431

Mycotic Coronary Artery Aneurysm From Fungal Prosthetic Valve Endocarditis

432

Mycotic false aneurysm of the ascending aorta

433

Mycotic infections in diabetic foot ulcers in Emam Reza hospital, Mashhad, 2006-2008

434

Mycotic infections in diabetic foot ulcers in Emam Reza hospital,Mashhad, 2006-2008

435

Mycotic Keratitis, a State-of-the-Art Review

436

Mycotic pseudoaneursym of the aortic arch: an unusual complication of invasive pulmonary aspergillosis

437

Mycotic pulmonary artery aneurysm diagnosed 18 years after bacterial endocarditis

438

Mycotoxicoses in veterinary medicine: Aspergillosis and penicilliosis

439

Mycotoxicosis in Swine: a Review

440

Mycotoxigenic and Proteolytic Potential of Moulds Associated with Smoked Shark Fish (Chlamydoselachus anguincus)

441

Mycotoxigenic Fusarium species in animal feed

442

Mycotoxin analyses in some home produced eggs in Belgium reveal small contribution to the total daily intake

443

Mycotoxin Contaminating Maize and Grass Silages for Dairy Cattle Feeding: Current State and Challenges

444

Mycotoxin Contamination of Foodstuffs and Feedstuffs in Iran

445

Mycotoxin Contamination of Maize Grains Grown in Karnataka (India)

446

Mycotoxin contamination of the feed supply chain: Implications for animal productivity and feed security

447

Mycotoxin content of organic and conventional oats from southeastern Poland

448

Mycotoxin fumonisin B1 selectively down-regulates the basal IL-8 expression in pig intestine: in vivo and in vitro studies

449

Mycotoxin Genetics and Gene Clusters

450

Mycotoxin glucosylation in commercial wheat varieties: Impact on resistance to Fusarium graminearum under laboratory and field conditions

451

Mycotoxin Management in Agriculture: a Review

452

Mycotoxin management in the European cereal trading sector

453

Mycotoxin occurrence in beer produced in several European countries

454

Mycotoxin occurrence in corn meal and flour traded in São Paulo, Brazil

455

Mycotoxin problem in Africa: Current status, implications to food safety and health and possible management strategies

456

Mycotoxin Production and Molecular Variability of European and American Isolates of Fusarium Culmorum

457

Mycotoxin production by Alternaria alternata strains isolated from red delicious apples in Argentina

458

Mycotoxin production by Alternaria strains isolated from Argentinean wheat

459

Mycotoxin production by Aspergillus, Fusarium and Penicillium species

460

Mycotoxin production by isolates of Fusarium lactis from greenhouse sweet pepper (Capsicum annuum)

461

Mycotoxin production in major crops as influenced by growing, harvesting, storage and processing, with emphasis on the achievement of Food Safety Objectives

462

Mycotoxin production of selected Fusarium species at different culture conditions

463

Mycotoxin protocols: Mary W. Trucksess and Albert E. Pohland (Eds.), Methods in Molecular Biology Inc., Volume 157, John M. Walker, Series Editor, Humana Press, Totowa, New Jersey 07512; 2000; hardback, pp xii+ 244; US$79.50; ISBN 0-089603-623-5; Website:

464

Mycotoxin Regulations for Foods: A Global Update

465

Mycotoxin research and mycoflora in some commercially important agricultural commodities

466

Mycotoxin risk evaluation in feeds contaminated by Aspergillus fumigatus

467

Mycotoxin-degradation profile of Rhodococcus strains

468

Mycotoxin-producing potential of fungi isolated from amaranth seeds in Argentina

469

470

Mycotoxins and food safety.: J.W. DeVries, M.W. Trucksess, L.S. Jackson (Eds.), 2002, Vol. 504, Advances in Experimental Medicine and Biology. Kluwer Academic, New York. 295+xi pp. ISBN 0-306-46780-1. Price?

471

Mycotoxins and food safety: Editors: Jonathan W. Devries, Mary W. Trucksess, and Lauren S. Jackson. Advances in Experimental Medicine and Biology, Vol. 504. Kluwer Academic, New York; xi+295 pp.; hardback, EUR 148.00/USD 135.00/GBP 94.00; ISBN 0-306-46780

472

Mycotoxins and phycotoxins. Advances in determination, toxicology and exposure management

473

Mycotoxins and Phycotoxins: Advances in Determination, Toxicology and Exposure Management, H. Njapeu, S. Trujillo, H. van Egmond, D. Pard (Eds.). Wageningen Academic Publishers (2006), ISBN: 978-90-8686-007-4

474

MYCOTOXINS AND SURFACE AND INTERNAL FUNGI OF MAIZE FROM ETHIOPIA

475

Mycotoxins and the pet food industry: Toxicological evidence and risk assessment

476

Mycotoxins and their effects on human and animal health

477

Mycotoxins Contamination in Tea and Herbal Infusion: A Mini-Review

478

Mycotoxins in a changing global environment – A review

479

Mycotoxins in Agriculture and Food Safety. K. K. Sinha and D. Bhatnagar (eds). 15.5 × 23.4 cm, 520 pp. New York, USA: Marcel Dekker [ http://www.dekker.com], 1998. $175. ISBN 0824701925 (hardback).

480

Mycotoxins in Brazilian corn for animal feed: occurrence and incentives for the private sector to control the level of contamination

481

Mycotoxins in cereals and cereal products in Slovenia – Official control of foods in the years 2008–2012

482

Mycotoxins in edible tree nuts

483

Mycotoxins in food from Jordan: Preliminary survey

484

Mycotoxins in food products available in Qatar

485

Mycotoxins in Food. Detection and Control, N. Magan, M. Olsen (Eds.). Woodhead Publishing Limited, Boca Raton, Boston, New York, Washington, DC, Cambridge (2004), ISBN: 1-85573-7337

486

Mycotoxins in fruits and their processed products: Analysis, occurrence and health implications

487

Mycotoxins in myelopathies of man

488

Mycotoxins in rice

489

Mycotoxins in Silages: Occurrence and Prevention

490

Mycotoxins in two Spanish cheese varieties

491

Mycotoxins occurrence in Argentina’s maize (Zea mays L.), from 1999 to 2010

492

Mycotoxins of Aspergilius fumigatus in pure culture and in native bioaerosols from compost facilities

493

Mycotoxins produced by Fusarium genus in maize: determination by screening and confirmatory methods based on liquid chromatography tandem mass spectrometry

494

Mycotoxins Produced by Fusarium spp. in Isogenic Bt vs. non-Bt Maize Hybrids under European Corn Borer Pressure

495

Mycotoxins: Occurrence, toxicology, and exposure assessment

496

Mycotoxins’ Toxicities - from Consumer Health Safety Concerns, to Mitigation/Treatment Strategies: A Perspective Review

497

Mycotrienins: A new class of potent inhibitors of osteoclastic bone resorption

498

MYCOTROPHIC STRATEGY OF 13 COMMON NEOTROPICAL TREES AND SHRUBS

499

Myctophid feeding ecology and carbon transport along the northern Mid-Atlantic Ridge

500

MyD88 pathway is involved in IL-18-mediated increase in intestine matrix metalloproteinase-9

501

Myectomy or Alcohol Septal Ablation: Surgery and Percutaneous Intervention Go Another Round

502

Myelin basic protein and ischemia modified albumin levels in acute ischemic stroke cases

503

Myelin Basic Protein is Down-Regulated in Sheep Affected with Ovine Coenurosis

504

Myelin basic protein—diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis

505

Myelin basic protein–lipid complex: an atomic force microscopy study

506

Myelin basic protein-specific T lymphocytes proliferation and programmed cell death in demyelinating diseases

507

Myelin breakdown in Alzheimer’s disease: a commentary

508

Myelin breakdown mediates age-related slowing in cognitive processing speed in healthy elderly men

509

Myelin characterization of fetal brain with mono-point estimated T1-maps

510

Myelin enhancement of Multiple sclerosis model with gold nanoparticles into the corpus callosum

511

Myelin Formation and Remodeling

512

Myelin Gene Regulatory Factor Is a Critical Transcriptional Regulator Required for CNS Myelination

513

Myelin glycoproteins targeted by lead in the rodent model of prolonged exposure

514

Myelin growth and coiling

515

Myelin Is a Preferential Target of Aluminum-Mediated Oxidative Damage

516

Myelin Membrane Wrapping of CNS Axons by PI(3,4,5)P3-Dependent Polarized Growth at the Inner Tongue

517

Myelin peptides in multiple sclerosis

518

Myelin Protection by Ursolic Acid in Cuprizone-Induced Demyelination in Mice

519

Myelin Proteolipid Protein-Induced Th1 and Th2 Clones Express TCR with Similar Fine Specificity for Peptide and CDR3 Homology Despite Diverse Vβ Usage

520

Myelin-Basic Protein-reactive Specific CD4+ and CD8+ NK Lymphocytes Induce Morphological Changes in Neuronal Cell Bodies and Myelin Sheaths: Implications for Multiple Sclerosis

521

Myelin-like protrusions of giant phospholipid vesicles prepared by electroformation

522

Myelin-Liposome Protection against Experimental Autoimmune Encephalomyelitis Is Associated with Reduced Neuroantigen-Specific T-Cell-Mediated Responses

523

Myelin-Oligodendrocyte Glycoprotein Antibodies Spectrum Disorders

524

Myelin-reactive antibodies mediate the pathology of MBP–PLP fusion protein MP4-induced EAE

525

Myelitis due to enterovirus in patient on interferon therapy for chronic hepatitis B: Case report

526

Myeloablative and immunosuppressive properties of treosulfan in mice

527

Myelodysplasia and Mast Cell Leukemia with t(9;22)

528

Myelodysplasia or Myeloneoplasia: Thoughts on the Nosology of Clonal Myeloid Diseases

529

Myelodysplasia with der(1;7)(q10;p10) discovered after an episode of bacterial lymphangitis in a twenty-three-year-old man

530

Myelodysplasia: The good, the fair and the ugly

531

Myelodysplasia: When to treat and how

532

Myelodysplasia-Like Syndrome and End-Stage Liver Disease

533

Myelodysplasic syndromes: A comprehensive review

534

Myelodysplastic features and cellular senescence in autoimmune disorders: a pilot study on patients with collagen tissue disorders and immune thrombocytopenic purpura

535

Myelodysplastic syndrome accompanied by basophilia and eosinophilia with t(5;12)(q31;p13)

536

Myelodysplastic Syndrome after Regression of Transient Abnormal Myelopoiesis in a Down Syndrome Infant: Different Clonal Origin?

537

Myelodysplastic syndrome and a nonrandom chromosomal abnormality t(1;19):: an indolent pathologic entity

538

Myelodysplastic syndrome and aortic valve replacement: additions

539

Myelodysplastic Syndrome Associated with Monosomy 7 in a Child with Bloom Syndrome

540

Myelodysplastic syndrome associated with monosomy 7 in childhood: a retrospective study

541

Myelodysplastic syndrome in a child with constitutional trisomy 8 mosaicism and normal phenotype

542

Myelodysplastic syndrome in an infant: induction of remission by cyclosporin

543

Myelodysplastic Syndrome Manifesting As Sweet’s Syndrome and Brochiolitis Obliterative Organizing Pneumonia

544

Myelodysplastic syndrome presenting with clonal rearrangement isolated to chromosomal region 1q

545

Myelodysplastic Syndrome with 6q Deletion as the Sole Chromosome Abnormality in an Iranian Patient: A Case Report with Review of Literature

546

Myelodysplastic Syndrome with Atypical Eosinophilia in Association with Ring Chromosome 7: A Case Report

547

Myelodysplastic syndrome with biclonal monosomy 7 and trisomy 8 after treatment with cladribine (2-chloro-2-deoxyadenosine) and involved field radiation therapy

548

Myelodysplastic Syndrome with Clonal Eosinophilia Accompanied by Eosinophilic Pulmonary Interstitial Infiltration

549

Myelodysplastic Syndrome with Hypereosinophilia and a Nonrandom Chromosomal Abnormality dic(1;7): Confirmation of Eosinophil Clonal Involvement by Fluorescence In Situ Hybridization

550

Myelodysplastic syndrome with isochromosome 5p and trisomy 8 after treatment of a multiple myeloma

551

Myelodysplastic syndrome with monosomy 7 in a patient with XY gonadal dysgenesis (incomplete testicular feminization)

552

Myelodysplastic syndrome with transformation to AML-M7 in a 46,XX male patient

553

Myelodysplastic Syndromes (MDS); diagnosis, classification, treatment and monitoring

554

Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing

555

Myelodysplastic syndromes with isolated deletion of the long arm of the chromosome X as a sole cytogenetic change

556

Myelodysplastic Syndromes With Nephrotic Syndrome

557

Myelofibrosis due to Secondary Hyperparathyroidism in a Case of Celiac Disease

558

Myelofibrosis in a 24-Year Old Nigerian

559

Myelofibrosis with myeloid metaplasia: Disease overview and non-transplant treatment options

560

Myelogenous leukemia in adult inbred MHC-defined miniature swine: A model for human myeloid leukemias

561

Myelogenous leukemia in adult inbred MHC-defined miniature swine: A model for human myeloid leukemias

562

Myelographic Applications in Newborn Healthy and Paraplegic Calves

563

Myeloid Antigen-positive T Cell Acute Lymphocytic Leukemia with t(14;18) and Trisomy 10: Report of a Case and Literature Review

564

Myeloid Cell Leukemia-1 (MCL-1) siRNA Therapy Showed Cytotoxic Effect on T Cells Acute Lymphoblastic Leukemia

565

Myeloid Cell Leukemia-1 Gene Expression and Clinicopathological Features in Myelodysplastic Syndrome

566

Myeloid cell leukemia-1 is a key molecular target for mithramycin A-induced apoptosis in androgen-independent prostate cancer cells and a tumor xenograft animal model

567

Myeloid cell trafficking and tumor angiogenesis

568

Myeloid differentiation (MyD) primary response genes in hematopoiesis

569

Myeloid differentiation in long term culture of human peripheral blood

570

Myeloid Leukemia Development in c-Cbl RING Finger Mutant Mice Is Dependent on FLT3 Signaling

571

Myeloid lineage of high proliferative potential human smooth muscle outgrowth cells circulating in blood and vasculogenic smooth muscle-like cells in vivo

572

Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs

573

Myeloid Progenitor Cell Proliferation and Mobilization Effects of BB10010, a Genetically Engineered Variant of Human Macrophage Inflammatory Protein-1α, in a Phase I Clinical Trial in Patients with Relapsed/Refractory Breast Cancer

574

Myeloid related protein (MRP) 14 expressing monocytes infiltrate atherosclerotic lesions of ApoE null mice

575

Myeloid Sarcoma after Allogenic Stem Cell Transplantation forAcute Myeloid Leukemia: Successful Consolidation TreatmentApproaches in Two Patients

576

Myeloid sarcoma of the orbit

577

Myeloid Sarcoma of the peritoneum at older ages: A case report and review of literature

578

Myeloid sarcoma of the urinary bladder with cutaneous tumour seeding after percutaneous suprapubic catheterization

579

Myeloid Sarcoma Presenting as Rectosigmoid Tumour: A Case Report

580

Myeloid Sarcoma Presenting with Lateral Cervical Mass and Eosinophilia; a Diagnostic and Therapeutic Dilemma: Case Report

581

Myeloid Sarcoma: Case Series with Unusual Locations

582

Myeloid/natural killer cell precursor acute leukemia with tetraploidy

583

Myeloid-derived suppressor cell role in tumor-related inflammation

584

Myeloid-derived suppressor cells are increased in frequency but not maximally suppressive in peripheral blood of Type 1 Diabetes Mellitus patients

585

Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice

586

Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice

587

Myeloid-lymphoid initiating cells (ML-IC) are highly enriched in the rhodamine-c-kit+CD33−CD38− fraction of umbilical cord CD34+ cells

588

Myelolipomas and other fatty tumours of the adrenals

589

Myeloma aetiology and epidemiology

590

Myeloma appearance after local external beam radiotherapy jet: Is it a new entity?

591

Myeloma Ascites-A Favorable Outcome With Cyclophosphamide Therapy

592

Myeloma bone disease

593

Myeloma cells (5TMM) and their interactions with the marrow microenvironment

594

Myelomatous Pleural Effusion Case report and review of the literature

595

Myelomeningocele: Characterization of a surgically induced sheep model and its central nervous system similarities and differences to the human disease

596

Myelopathy due to hereditary multiple exostoses: CT and MR studies

597

Myelopathy following high voltage electrical injury: a case report

598

Myeloperoxidase (MPO)-specific CD4+ T cells contribute to MPO-anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis

599

Myeloperoxidase −463G > A polymorphism and risk of primary lung cancer in a Korean population

600

Myeloperoxidase activity in chicken heterophils and adherent cells

601

Myeloperoxidase activity in chicken heterophils and adherent cells

602

Myeloperoxidase activity, fibrinogen concentrations and white blood cell counts in healthy and sick foals

603

Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure

604

Myeloperoxidase and C-Reactive Protein Have Combined Utility for Long-Term Prediction of Cardiovascular Mortality After Coronary Angiography

605

Myeloperoxidase and Horseradish Peroxidase Catalyze Tyrosine Nitration in Proteins from Nitrite and Hydrogen Peroxide

606

Myeloperoxidase as a Biomarker in Acute Coronary Syndrome: Beware of the Pitfalls

607

Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion

608

Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: Genetic determinants for atherosclerosis?

609

Myeloperoxidase in Equine Semen: Concentration and Localization during Freezing Processing

610

Myeloperoxidase levels are not associated with carotid atherosclerosis progression in patients with familial hypercholesterolemia

611

Myeloperoxidase Levels in Patients with PCOS and/or Obesity Before and After Metformin Treatment

612

Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease

613

Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome

614

Myeloperoxidase Predicts Progression of Carotid Stenosis in States of Low High-Density Lipoprotein Cholesterol Original Research Article

615

Myeloperoxidase-antineutrophil cytoplasmic antibody-associated sensorineural hearing loss

616

Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patients

617

Myeloperoxidase-catalyzed formation of PCDD/F from chlorophenols

618

Myeloperoxidase-Catalyzed Oxidation of Tyrosine

619

Myeloperoxidase-catalyzed redox-cycling of phenol promotes lipid peroxidation and thiol oxidation in HL-60 cells

620

Myeloperoxidase-catalyzed taurine chlorination: Initial versus equilibrium rate

621

Myeloperoxidase-Dependent Generation of a Tyrosine Peroxide by Neutrophils

622

Myeloperoxidase-Dependent Loss of Malondialdehyde: A Limitation for Detecting Neutrophil-Mediated Lipid Peroxidation

623

Myeloperoxidase-generated oxidants and atherosclerosis

624

Myeloperoxidase-induced formation of chlorohydrins and lysophospholipids from unsaturated phosphatidylcholines

625

Myeloperoxidase-mediated oxidation of high-density lipoproteins: Fingerprints of newly recognized potential proatherogenic lipoproteins

626

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

627

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

628

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

629

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

630

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

631

Myelopoiesis and erythropoiesis in canine visceral leishmaniasis

632

Myelopoietin, a chimeric agonist of human interleukin 3 and granulocyte colony-stimulating factor receptors, mobilizes CD34+ cells that rapidly engraft lethally x-irradiated nonhuman primates

633

Myeloproliferative disorders

634

Myeloproliferative disorders and its associated mutations

635

Myeloproliferative Neoplasm with Prominent Eosinophilia

636

Myeloproliferative Neoplasms Associated with Mutation in JAK2V617F and Tyrosine Kinase Inhibitors as Therapeutic Strategy

637

Myeloproliferative Neoplasms Associated with Mutation in JAK2V617F and Tyrosine Kinase Inhibitors as Therapeutic Strategy

638

Myeloproliferative stem cell disorders by deregulated Rap1 activation in SPA-1-deficient mice

639

Myeloprolipherative Disorder Type Chronic Myeloid Leucemia - Eosinophilic Form

640

Myeloprotection following cytotoxic damage: The sooner the better

641

Myeloprotective effect of Triticum aestivum Linn. grass against antineoplastic agents induced bone marrow toxicity in mice

642

Myenteric Denervation of the Gut with Benzalkonium Chloride: A Review of Forty Years of an Experimental Model

643

Myenteric denervation reduces the incidence of gastric tumors in rats

644

Myenteric plexus injury and apoptosis in experimental colitis

645

Myers effect and tachyon condensation Original Research Article

646

Myerson values for games with fuzzy communication structure

647

Myf-5 Revisited: Loss of Early Myotome Formation Does Not Lead to a Rib Phenotype in Homozygous Myf-5 Mutant Mice

648

Myhill–Nerode type theory for fuzzy languages and automata

649

650

Myiasis among slaughtered animals in Kashan, Iran: descriptive a veterinary entomological problem in the tropics

651

Myiasis in an 89-year-old man with non-hodgkin lymphoma.

652

Myiasis in Animals and Humans in Northeastern Anatolia

653

Myiasis of Mandible Due to Lucilia sericata, in Diabetic Woman Patient: A Case Report

654

Myiasis With Carcinoma in Situ of the Glans Penis: An Unusual Combination

655

MyLake—A multi-year lake simulation model code suitable for uncertainty and sensitivity analysis simulations

656

MyLake—A multi-year lake simulation model code suitable for uncertainty and sensitivity analysis simulations

657

Mylar™ and Teflon-AF™ as cell culture substrates for studying endothelial cell adhesion

658

MyLearningMentor: A Mobile App to Support Learners Participating in MOOCs

659

MyLifeBits: holding on to the present to preserve the past

660

Mylonite development in the Hercynian basement of Sardinia (Italy)

661

Mylonitic deformation of gabbro in the lower crust: A case study from the Pankenushi gabbro in the Hidaka metamorphic belt of central Hokkaido, Japan

662

Mylonitization in the lower plate of the Buckskin-Rawhide detachment fault, west-central Arizona: Implications for the geometric evolution of metamorphic core complexes

663

MyMessage: case-based reasoning and multicriteria decision making techniques for intelligent context-aware message filtering

664

Myo- and hepatotoxic effects of cultivated mushrooms in mice

665

MYO/ENDOTHELIAL DIFFERENTIATION OF HUMAN UMBILICAL CORD BLOOD-DERIVED STEM CELLS IN ISCHEMIC LIMB TISSUES

666

Myoblast alignment and differentiation on cell culture substrates with microscale topography and model chemistries

667

Myoblast proliferation and differentiation on fibronectin-coated self assembled monolayers presenting different surface chemistries

668

Myoblast Transplantation for Cardiac Repair: From Automyoblast to Allomyoblast Transplantation

669

Myoblast transplantation for heart failure

670

Myoblast transplants challenged in muscular dystrophy

671

Myoblasts and fibroblasts in stress urinary incontinence

672

Myocardial 99m-Tc tetrofosmin reverse redistribution as a possible marker of tissue at risk

673

Myocardial abscess with contained rupture: successful repair

674

Myocardial adaptation and efficiency in response to intensive physical training in elite speedskaters

675

Myocardial adaptation to ischaemia – the preconditioning phenomenon

676

Myocardial adenine nucleotides, glycogen, and Na,K-ATPase in patients with idiopathic dilated cardiomyopathy requiring mechanical circulatory support

677

Myocardial adrenergic nervous activity is intensified in patients with heart failure without left ventricular volume or pressure overload

678

Myocardial and cerebral oxygen delivery are not adversely affected by cocaine administration to early-gestation fetal sheep, , ,

679

Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10

680

Myocardial and microcirculatory kinetics of BR14, a novel third-generation intravenous ultrasound contrast agent

681

Myocardial and pulmonary effects of aqueous oxygen with acute hypoxia

682

Myocardial and Systemic Iron Depletion in Heart Failure: Implications for Anemia Accompanying Heart Failure

683

Myocardial and vascular dysfunction in systemic sclerosis: The potential role of noninvasive assessment in asymptomatic patients

684

Myocardial anti-ischemic effect of BRX-235: Role of nitric oxide and reactive oxygen species

685

Myocardial Apoptosis and Infarction after Ischemia/Reperfusion Are Attenuated by κ-Opioid Receptor Agonist

686

Myocardial apoptosis in heterotopic murine heart transplant model of chronic rejection/graft vasculopathy

687

Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM Trial): Clinical Feasibility Study

688

Myocardial Atrophy and Chronic Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Assist Device–Induced Myocardial Recovery

689

Myocardial atrophy in acquired immunodeficiency syndrome—associated wasting

690

Myocardial beta-adrenoceptor density and plasma catecholamines in syndrome X

691

Myocardial beta-adrenoceptor densityone month after acute myocardial infarctionpredicts left ventricular volumes at six months

692

Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy

693

Myocardial blood flow after chronic cardiac decentralization in anesthetized dogs: effects of ACE-inhibition

694

Myocardial blood flow and coronary flow reserve late after anatomical correction of transposition of the great arteries

695

Myocardial blood flow and efficiency in concentric and eccentric left ventricular hypertrophy

696

Myocardial blood supply by left ventricle-to-coronary artery channel: An old idea revisited

697

Myocardial blood-flow response during mental stress in patients with coronary artery disease

698

Myocardial bridge over the left anterior descending coronary artery: A case report and review of the literature

699

Myocardial Bridge: Surgical Outcome and Mid-term Follow up

700

Myocardial Bridging

701

Myocardial bridging causing transmural ischemia Successful coronary artery bypass surgery

702

Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease

703

Myocardial bridging in adult and pediatric patients with hypertrophic cardiomyopathy is not associated with poor outcome

704

Myocardial bridging in adult patients with hypertrophic cardiomyopathy

705

Myocardial bridging of coronary arteries: A risk factor for myocardial fibrosis?

706

Myocardial bridging of obtuse marginal branch of the left circumflex artery associated with congenital corrected transposition of the great arteries

707

Myocardial bridging of the left anterior descending coronary artery in children with hypertrophic cardiomyopathy

708

Myocardial bridging of the left anterior descending coronary artery in children with hypertrophic cardiomyopathy: Reply

709

Myocardial bridging of the posterolateral branches of the right coronary artery

710

Myocardial bridging of the ramus intermedius coronary artery

711

Myocardial bridging of the right coronary artery and emotional stress: A fatal link?

712

Myocardial bridging on left anterior descending coronary artery evaluated by multidetector computed tomography

713

Myocardial Bridging: Contemporary Understanding of Pathophysiology With Implications for Diagnostic and Therapeutic Strategies

714

Myocardial buffering capacity in ischemia preconditioned rat heads

715

Myocardial Capillaries and Coronary Flow Reserve

716

Myocardial capillary density in normal and diabetic male rats: Effect of bezafibrate

717

Myocardial capillary supply is limited in hypertrophic cardiomyopathy: A morphological analysis

718

Myocardial cell damage in human hypertension

719

Myocardial Cell Death and Apoptosis in Hibernating Myocardium

720

Myocardial cell lineages in the mammalian embryo: The second heart field

721

Myocardial collagen and fibronectin levels in patients with pulmonary atresia and ventricular septal defect

722

Myocardial Connexin43 Expression in Left Ventricular Hypertrophy Resulting from Aortic Regurgitation

723

Myocardial contractile dispersion: A new marker for the severity of cirrhosis?

724

Myocardial contractile dysfunction contributes to the development of heart failure in rats with aortic stenosis

725

Myocardial Contractile Effects of image-Arginine in the Human Allograft

726

Myocardial Contractile Reserve Accurately Predicts Positive Response to Cardiac Resynchronization Therapy

727

Myocardial contractile reserve on dobutamine echocardiography predicts late spontaneous improvement in cardiac function in patients with recent onset idiopathic dilated cardiomyopathy

728

Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy

729

Myocardial Contractile Responsiveness to Endothelin-1 in the Post-infarction Rat Model of Heart Failure: Effects of Chronic Quinapril

730

Myocardial contraction fraction: a volumetric index of myocardial shortening by freehand three-dimensional echocardiography

731

Myocardial contrast echo effect: The dilemm of coronary blood flow and volume

732

Myocardial contrast echocardiography accurately reflects transmurality of myocardial necrosis and predicts contractile reserve after acute myocardial infarction

733

Myocardial Contrast Echocardiography Demonstrates That Collateral Flow Can Preserve Myocardial Function Beyond a Chronically Occluded Coronary Artery

734

Myocardial Contrast Echocardiography Evolving as a Clinically Feasible Technique for Accurate, Rapid, and Safe Assessment of Myocardial Perfusion: The Evidence So Far Review Article

735

Myocardial contrast echocardiography for the detection of coronary artery disease

736

Myocardial Contrast Echocardiography for the Detection of Coronary Artery Stenosis: A Prospective Multicenter Study in Comparison With Single-Photon Emission Computed Tomography Original Research Article

737

Myocardial contrast echocardiography in acute myocardial infarction

738

Myocardial Contrast Echocardiography in Acute Myocardial Infarction Using Aortic Root Injections of Microbubbles in Conjunction With Harmonic Imaging: Potential Application in the Cardiac Catheterization Laboratory

739

Myocardial contrast echocardiography in human beings: Correlation of resting perfusion defects to sestamibi single photon emission computed tomography

740

Myocardial Contrast Echocardiography Perfusion Imaging: Still Waiting After All These Years

741

Myocardial contrast echocardiography to assess spontaneous reperfusion during myocardial infarction

742

Myocardial Contrast Echocardiography Versus Dobutamine Echocardiography for Predicting Functional Recovery After Acute Myocardial Infarction Treated With Primary Coronary Angioplasty

743

Myocardial Contrast Echocardiography Versus Thrombolysis in Myocardial Infarction Score in Patients Presenting to the Emergency Department With Chest Pain and a Nondiagnostic Electrocardiogram Original Research Article

744

Myocardial contrast echocardiography with a new calibration method can estimate myocardial viabilityin patients with myocardial infarction Original Research Article

745

Myocardial contrast echocardiography with power Doppler imaging

746

Myocardial contrast echocardiography, single-photon emission computed tomography, and regional function analysis for coronary stenosis description during vasodilator stress

747

Myocardial Contrast Echocardiography: An Innovative Technique to Assess Myocardial Perfusion in Hypertensive Patients

748

Myocardial contrast echocardiography: relation of collateral perfusion to extent of injury and severity of contractile dysfunction in canine model of coronary thrombosis and reperfusion

749

Myocardial contrast echocardiography: Reliable, safe, and efficacious myocardial perfusion assessment after intravenous injections of a new echocardiographic contrast agent

750

Myocardial contrast versus dobutamine echocardiography as predictors of late functional recovery in acute myocardial infarction treated with primary PTC

751

Myocardial creatine kinase expression after left ventricular assist device support

752

Myocardial cytochrome c oxidase activity in Swedish moose (Alces alces L.) affected by molybdenosis

753

Myocardial damage after continuous aerobic and anaerobic exercise in rats

754

Myocardial Damage After TAVR Assessed With CMR: A New Piece in a Puzzle?

755

Myocardial damage and left ventricular dysfunction in patients with and without persistent negative t waves after q-wave anterior myocardial infarction

756

Myocardial damage and repair

757

Myocardial damage does not occur in untreated hyperthyroidism unless associated with congestive heart failure, ,

758

Myocardial damage in multisystem inflammatory syndrome associated with COVID‑19 in children and adolescents

759

Myocardial damage of the entire ventricular region in a patient with acute myocardial infarction

760

Myocardial Deformation and Rotational Profiles in Mitral Valve Prolapse

761

Myocardial deformation and ventricular vortices: physically-based imaging in clinical practice

762

Myocardial Deformation Imaging Based on Ultrasonic Pixel Tracking to Identify Reversible Myocardial Dysfunction Original Research Article

763

Myocardial Deformation Imaging by Two-Dimensional Speckle-Tracking Echocardiography in Comparison to Late Gadolinium Enhancement Cardiac Magnetic Resonance for Analysis of Myocardial Fibrosis in Severe Aortic Stenosis

764

Myocardial Deformation Indices in Patients with Significant Aortic Regurgitation: A Strain Rate Imaging Study

765

Myocardial deformation recovery from cine MRI using a nearly incompressible biventricular model

766

Myocardial Delayed Enhancement by Magnetic Resonance Imaging in Patients With Chagas’ Disease: A Marker of Disease Severity Original Research Article

767

Myocardial Delayed Enhancement by Magnetic Resonance Imaging in Patients With Muscular Dystrophy Original Research Article

768

Myocardial diastolic dysfunction at experimental diabetes mellitus—the role of nitric oxide

769

Myocardial disarray: an architectural disorganization linked with adrenergic stress?

770

Myocardial Distribution of Antegrade Cold Crystalloid and Tepid Blood Cardioplegia

771

Myocardial Doppler velocity imaging—a quantitative technique for interpretation of dobutamine echocardiography

772

Myocardial dysfunction after resuscitation from cardiac arrest: An example of global myocardial stunning

773

Myocardial Dysfunction and Adrenergic Cardiac Innervation in Patients With Insulin-Dependent Diabetes Mellitus

774

Myocardial Dysfunction Caused by Perinatal Asphyxia in Full-term Infants

775

Myocardial Dysfunction in Thalassemia Major: Comparison between Echocardiography and MRI

776

Myocardial dysfunction with coronary microembolization: Signal transduction through a sequence of no, TNFα and sphingosine

777

Myocardial Dysfunction: A Primary Cause of Death Due To Severe Malaria in A Plasmodium falciparum-Infected Humanized Mouse Model.

778

Myocardial dysfunction: hibernation and remodelling

779

Myocardial dysfunction: hibernation and remodelling

780

Myocardial edema: Comparison of effects on filling volume and stiffness of the left ventricle in rats and pigs

781

Myocardial effects of experimental acute brain death: Evaluation by hemodynamic and biological studies

782

Myocardial Effects of PDE5 Inhibition: More Function With Less Mass

783

Myocardial electrical impedance responds to ischemia and reperfusion in humans

784

Myocardial endothelin-1 release and indices of inflammation during angioplasty for acute myocardial infarction and stable coronary artery disease

785

Myocardial enterovirus infection with left ventricular dysfunction: benign disease compared with idiopathic dilated cardiomyopathy

786

Myocardial epithelial inclusions in a Holstein calf

787

Myocardial Expression Levels of Micro-Ribonucleic Acids in Patients With Left Ventricular Assist Devices: Signature of Myocardial Recovery, Signature of Reverse Remodeling, or Signature With No Name?

788

Myocardial Expression of Endothelin-1 in Murine Trypanosoma cruzi Infection

789

Myocardial Expression of Fas and Recovery of Left Ventricular Function in Patients With Recent-Onset Cardiomyopathy Original Research Article

790

Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat

791

Myocardial Extracellular Matrix Remodeling with the Development of Pacing Induced Congestive Heart Failure: Contributory Mechanisms

792

Myocardial Extracellular Remodeling Is Associated With Ventricular Diastolic Dysfunction in Children and Young Adults With Congenital Aortic Stenosis

793

Myocardial Extracellular Volume by Cardiac Magnetic Resonance Imaging in Patients Treated With Anthracycline-Based Chemotherapy

794

Myocardial extramedullary hematopoiesis following myocardial infarction

795

Myocardial factor for timing of surgery in asymptomatic patients with mitral regurgitation

796

Myocardial fibrin deposits in the first month after transplantation predict subsequent coronary artery disease and graft failure in cardiac allograft recipients

797

Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with

798

Myocardial Fibrosis Associated with Aldosterone or Angiotensin II Administration: Attenuation by Calcium Channel Blockade

799

Myocardial fibrosis detected by cardiac magnetic resonance imaging in heart failure: impact on remodeling, diastolic function and BNP levels

800

Myocardial Fibrosis Identified by Cardiac Magnetic Resonance Late Gadolinium Enhancement Is Associated With Adverse Ventricular Mechanics and Ventricular Tachycardia Late After Fontan Operation

801

Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone

802

Myocardial Fibrosis in Transforming Growth Factor β1Heterozygous Mice

803

Myocardial Fibrosis Predicts Appropriate Device Therapy in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death

804

Myocardial Flow Reserve in Long-Term Survivors of Repair of Anomalous Left Coronary Artery From Pulmonary Artery

805

Myocardial flow reserve in patients with a systemic right ventricle after atrial switch repair

806

Myocardial function and geometry in hypertensive subjects with low levels of afterload

807

Myocardial Function in Egyptian Pediatric Patients With Acute Nephritic Syndrome

808

Myocardial function in hearts with transgenic overexpression of the G protein-coupled receptor kinase 5

809

Myocardial function in patients with multiple sclerosis treated with low-dose mitoxantrone

810

Myocardial Function in the Working Mouse Heart Overexpressing Cardiac A1Adenosine Receptors

811

Myocardial Function of Horses Under Sedation with Romifidine Using Two-Dimensional Speckle Tracking

812

Myocardial Function of Hyperthyroid Rats in Presence of Diazepam in Langendorff Setup

813

Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imaging

814

Myocardial Gene Expression in Heart Failure Patients Treated With Cardiac Resynchronization Therapy: Responders Versus Nonresponders Original Research Article

815

Myocardial gene expression of inflammatory cytokines after heart transplantation in relation to the development of transplant coronary artery disease

816

Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: Comparison with surgical and percutaneous intramyocardial gene delivery Original Research Article

817

Myocardial Glucose Transport and Utilization in Patients With Type 2 Diabetes Mellitus, Left Ventricular Dysfunction, and Coronary Artery Disease Original Research Article

818

Myocardial Glucose Transporter GLUT1: Translocation Induced by Insulin and Ischemia

819

Myocardial Glycogen Depletion Cannot Explain the Cardioprotective Effects of Ischemic Preconditioning in the Rat Heart

820

Myocardial high-energy phosphate metabolism in patients with stable chronic dilated cardiomyopathy under a dobutamine-induced prolonged mild workload,

821

Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines

822

Myocardial Hydatid Cyst : An Uncommon Complication of Echinococcal Infection

823

Myocardial hydrophilic polymer emboli following cardiac catheterization: a case report and literature review

824

Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats

825

Myocardial IL-6 regulation by neurohormones—an in vitro superfusion study

826

Myocardial imaging in patients with defibrillator patch electrodes

827

Myocardial imaging with a new transpulmonary lipid-fluorocarbon echo contrast agent: Experimental studies in pigs

828

Myocardial immediate early gene activation after cardiopulmonary bypass with cardiac ischemia-reperfusion

829

Myocardial indium-111 antimyosin uptake after uncomplicated coronary artery bypass surgery

830

Myocardial infarction after an ice-hockey match: Coincidence of myocardial bridging and coronary spasm

831

Myocardial infarction after aspirin cessation in stable coronary artery disease patients

832

Myocardial Infarction after Endoscopic Removal of Foreign Body

833

Myocardial Infarction After Oral Sumatriptan Use in a Woman with Normal Coronary Arteries

834

Myocardial infarction after partial left ventriculectomy

835

Myocardial infarction after partial left ventriculectomy: Reply

836

Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging Original Research Article

837

Myocardial infarction after vascular surgery: the role of prolonged, stress-induced, ST depression-type ischemia

838

Myocardial infarction and coronary care units

839

Myocardial infarction and depression: A review article

840

Myocardial infarction and heart failure—a dangerous intersection

841

Myocardial infarction and HELLP: a case of heightened vasomotor reactivity

842

Myocardial Infarction and Hyperglycemia

843

Myocardial infarction and ischemia

844

Myocardial infarction and left ventricular remodeling: Results of the CEDIM trial

845

Myocardial infarction and percent arteriographic stenosis of culprit lesion: Report from the Program on the Surgical Control of the Hyperlipidemias (POSCH) Original Research Article

846

Myocardial Infarction and Regulatory Myosin Light Chain

847

Myocardial infarction and sub-acute ventricular rupture: successful outcome in two cases

848

Myocardial infarction and venous thrombosis in a 42-year old woman with heterozygous methylenetetrahydrofolate reductase (MTHRF) gene mutation, hyperhomocysteinemia, and protein C deficiency

849

Myocardial infarction as a complication of new interventional devices

850

Myocardial infarction as complication of left atrial myxoma

851

Myocardial infarction caused by a large coronary artery aneurysm

852

Myocardial infarction caused by a leukemic clot: A case report

853

Myocardial Infarction Caused by Active-Fixation Ventricular Pacing Lead Screwed into the Anterior Descending Coronary Artery

854

Myocardial infarction caused by compression of the left coronary artery by an aortic pseudoaneurysm

855

Myocardial infarction caused by coronary artery myocardial bridge,

856

Myocardial infarction complicating the initial phase of an ovarian stimulation protocol

857

Myocardial infarction diagnosis by morphology of ventricular extrasystole

858

Myocardial infarction due to lightning strike

859

Myocardial infarction during menses: lessons from trials and errors

860

Myocardial infarction during scuba diving: A case report and review

861

Myocardial Infarction Elevates Inflammation and Contributes to the Formation of Atheroma Plaques in the Aorta of Hypercholesterolaemic Rats

862

Myocardial infarction following a bee sting

863

Myocardial infarction in a 35-day-old infant with incomplete Kawasaki disease and chicken pox

864

Myocardial Infarction in a newborn from a diabetic mother

865

Myocardial Infarction in a Patient with Prosthetic Aortic Valve

866

Myocardial infarction in a patient with thrombotic thrombocytopenic purpura

867

Myocardial infarction in a woman with no apparent risk factors

868

Myocardial infarction in a young athlete with non-obstructive hypertrophic cardiomyopathy and normal coronary arteries

869

Myocardial Infarction in a Young Patient After Acute Exposure to Carbon Monoxide

870

Myocardial infarction in a young woman with antiphospholipid syndrome

871

Myocardial infarction in children

872

Myocardial Infarction in Iran: Epidemiology, Management, and Prognosis

873

Myocardial infarction in isolated ventricular non-compaction: Contrast echo and MRI

874

Myocardial infarction in mice: Functional characterization and cytokine expression

875

Myocardial Infarction in Newly Diagnosed Hypertensive Medicaid Patients Free of Coronary Heart Disease and Treated with Calcium Channel Blockers

876

Myocardial Infarction in Patients with and without COVID-19: Comparisons of Characteristics, Clinical Courses, and Outcomes

877

Myocardial infarction in pregnant women — Case reports

878

Myocardial infarction in pre-war Leeds

879

Myocardial infarction in pre-war Leeds

880

Myocardial infarction in pre-war Leeds

881

Myocardial infarction in sickle-cell disease

882

Myocardial Infarction in the Absence of Obstructive Epicardial Coronary Disease

883

Myocardial infarction in the C57BL/6J mouse: A quantifiable and highly reproducible experimental model

884

Myocardial infarction in young adults: Angiographic characterization, risk factors and prognosis (coronary artery surgery study registry)

885

Myocardial infarction in young adults: Angiographic characterization, risk factors, and prognosis (Coronary Artery Surgery Study registry): Zimmerman FH, Cameron A, Fisher LD, et al J Am Coll Cardiol 26:654–661 September 1995

886

Myocardial infarction in young patients

887

Myocardial Infarction Induced by Migraine Therapy

888

Myocardial infarction occurrence in Jerusalem: a Mediterranean anomaly

889

Myocardial infarction or inflammation?

890

Myocardial infarction patients in the 1990s—their risk factors, stratification and survival in Canada: The Canadian assessment of myocardial infarction (CAMI) study

891

Myocardial infarction postpartum in patients taking bromocriptine for the prevention of breast engorgement

892

Myocardial infarction quantification with late gadolinium-enhanced magnetic resonance imaging in rats using a 7-T scanner

893

Myocardial infarction redefined: Impact on case-load and outcome of patients with suspected acute coronary syndrome and nondiagnostic ECG at presentation

894

Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction: The Joint European Society of Cardiology/ American College of Cardiolo

895

Myocardial Infarction Resulting From Caffeine Overdose in an Anorectic Woman, ,

896

Myocardial infarction resulting from nonatherosclerotic coronary artery diseases

897

Myocardial infarction risk in relation to zinc concentration in toenails

898

Myocardial infarction scar plication in the rat: cardiac mechanics in an animal model for surgical procedures

899

Myocardial Infarction Secondary to a Coronary Ostial Thrombus in Antiphospholipid Syndrome

900

Myocardial Infarction Secondary to Inflammatory Myofibroblastic Tumor Obstruction of the Left Main: Treated With Primary PCI

901

Myocardial infarction with huge mural thrombus due to spontaneous coronary artery dissection detected by 64-multidetector computed tomography

902

Myocardial infarction with spontaneous reperfusion in a young woman with hypertrophic cardiomyopathy

903

Myocardial infarction with thrombus formation during prolonged intense exercise

904

Myocardial infarction without coronary artery occlusion following mental stress

905

Myocardial infarction, Arg 506 to Gin factor V mutation, and activated protein C resistance

906

Myocardial infarction, ventricular remodeling, and angiotensin-converting enzyme inhibition: Where we stand today

907

Myocardial Infarction, Viral Infection, and the Cytoskeleton: Final Common Pathways of a Common Disease?

908

Myocardial infarction: a catabolic disease?

909

Myocardial infarction: a paradigm of success in modern medicine

910

Myocardial infarction: a rare complication of dothiepin overdose

911

Myocardial infarction: changing view of a killer

912

Myocardial infarction: From trials to practice : Ball SG (editor) Wrightson Biomedical Publishing Ltd., Hampshire, UK, 1995; 194 pp.; stg£32.50; ISBN 1-871816-26-2

913

Myocardial infarction: is evidence-based medicine the best?

914

Myocardial Infarction-triggered Thrombotic Microangiopathy

915

Myocardial inflammatory infiltrate in human chronic chagasic cardiomyopathy: Immunohistochemical findings

916

Myocardial Injury After Electrical Therapy for Cardiac Arrhythmias Assessed by Troponin-T Release

917

Myocardial injury during off-pump surgery. The effect of intraoperative risk factors

918

Myocardial injury in thrombotic thrombocytopenic purpura: A frequent, perplexing complication

919

Myocardial injury, neurohormonal activation and inflammation after internal atrial defibrillation

920

Myocardial injury-related changes in plasma NT-proBNP and ANP concentrations in a canine model of ischemic myocardial injury

921

Myocardial integrated ultrasonic backscatter in patients with dilated cardiomyopathy: Prediction of response to β-blocker therapy

922

Myocardial integrated ultrasonic backscatter in patients with old myocardial infarction: Comparison with radionuclide evaluation

923

Myocardial involvement in a patient with human ehrlichiosis

924

Myocardial involvement in Takayasu arteritis

925

Myocardial Iodine-123 Meta-Iodobenzylguanidine Imaging and Cardiac Events in Heart Failure: Results of the Prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) Study

926

Myocardial iron load measured by cardiac magnetic resonance imaging to evaluate cardiac systolic function in thalassemia

927

Myocardial ischaemia

928

Myocardial ischaemia un-masked by transesophageal atrial pacing combined with two-dimensional transthoracic echocardiography in a pediatric patient: a case report

929

Myocardial ischaemia with a normal coronary angiogram due to the primary antiphospholipid syndrome

930

Myocardial Ischemia Activates the JAK–STAT Pathway Through Angiotensin II Signaling in in vivo Myocardium of Rats

931

Myocardial ischemia and autonomic activity in dippers and non-dippers with coronary artery disease: assessment of normotensive and hypertensive patients

932

Myocardial Ischemia and Infarction Review Article

933

Myocardial Ischemia and Infarction Review Article

934

Myocardial ischemia and infarction Review Article

935

Myocardial ischemia and reperfusion injury

936

Myocardial ischemia and ventricular fibrillation: Pathophysiology and clinical implications

937

Myocardial Ischemia and Ventricular Tachycardia on Continuous Electrocardiographic Monitoring and Risk of Cardiovascular Outcomes After Non–ST-Segment Elevation Acute Coronary Syndrome (from the MERLIN-TIMI 36 Trial)

938

Myocardial ischemia caused by a coronary anomaly left anterior descending coronary artery arising from right sinus of Valsalva

939

Myocardial Ischemia Caused by an Abnormal Origin and Course of the Left Coronary Artery in an Adult

940

Myocardial ischemia caused by cold-water submersion

941

Myocardial ischemia caused by external compression due to shotgun bullets

942

Myocardial ischemia due to coronary artery spasm during dobutamine stress echocardiography

943

Myocardial ischemia during physical exercise in patients with stable coronary artery disease: predictability and prevention

944

Myocardial ischemia during sexual activity in patients with coronary artery disease

945

Myocardial ischemia in generalized coronary artery–left ventricular microfistulae

946

Myocardial Ischemia Induced by Rapid Atrial Pacing Causes Troponin T Release Detectable by a Highly Sensitive Assay: Insights From a Coronary Sinus Sampling Study

947

Myocardial ischemia induced by topical use of 5-fluorouracil

948

Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process

949

Myocardial Ischemic Injury and Purine Metabolism in Patients Undergoing Coronary Artery Bypass

950

Myocardial ischemic injury during cardiopulmonary by-pass: Evaluation of purine compounds by capillary electrophoresis

951

Myocardial ischemic post-conditioning protects the lung against myocardial ischemia/reperfusion-induced damage by activating GSK-3β

952

Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome

953

Myocardial kinematics from tagged MRI based on a 4-D B-spline model

954

Myocardial Kinetics of 99mTechnetium-Q Agents Studies in Isolated Cardiac Myocyte, Isolated Perfused Rat Heart, and Canine Regional Myocardial Ischemia Models

955

Myocardial kinetics of technetium-99m teboroxime in the presence of postischemic injury, necrosis and low flow reperfusion

956

Myocardial lactate dehydrogenase subunit ratio in cardiac allograft recipients

957

Myocardial laser revascularization for the treatment of end-stage coronary artery disease

958

Myocardial laser revascularization: the controversy and the data

959

Myocardial Late Enhancement in Duchenne and Becker Individuals in the Clinical Milieu

960

Myocardial Metabolic Abnormality in a Primary Left Atrial Rhabdomyosarcoma: Localized 1H MR Spectroscopy

961

Myocardial metabolism and hemodynamics during coronary surgery without cardiopulmonary bypass

962

Myocardial Metabolism is Better Preserved After Blood Cardioplegia in Infants

963

Myocardial microvascular abnormalities observed by intravenous myocardial contrast echocardiography in patients with hypertrophic cardiomyopathy

964

Myocardial mitochondrial calcium accumulation modulates nuclear calcium accumulation and DNA fragmentation

965

Myocardial Motion Analysis From B-Mode Echocardiograms

966

Myocardial myotonia in myotonic muscular dystrophy

967

Myocardial necrosis in “pure unstable angina”: Identification of high-risk subgroups or a contradiction in terms?, ,

968

Myocardial neutrophil infiltration, lipid peroxidation, and antioxidant activity after coronary artery thrombosis and thrombolysis

969

Myocardial No-Reflow in Humans

970

Myocardial outflow of prostacyclin in relation to metabolic stress during off-pump coronary artery bypass grafting

971

Myocardial Oxygen Consumption Modulates Adenosine Formation by Canine Right Ventricle in Absence of Hypoxia

972

Myocardial oxygen consumption: The quest for its determinants and some clinical fallout

973

Myocardial oxygen consumption: the quest for its determinants and some clinical fallout

974

Myocardial Oxygen Tension and Relative Capillary Density in Isolated Perfused Rat Hearts

975

Myocardial Oxygen Tension in Isolated Erythrocyte-perfused Rat Hearts and Comparison with Crystalloid Medi

976

Myocardial Oxygenation During Terminal Warm Blood Cardioplegia

977

Myocardial Oxygenation in Coronary Artery Disease: Insights From Blood Oxygen Level–Dependent Magnetic Resonance Imaging at 3 Tesla

978

Myocardial parasite persistence in chronic chagasic patients

979

Myocardial pathological changes in overtraining exercise

980

Myocardial perforation associated with the use of the Gensini ventriculography catheter

981

Myocardial performance after graft preservation and subsequent cardiac transplantation from brain-dead donors

982

Myocardial performance after successful intervention for native aortic coarctation

983

Myocardial Performance after Successful Liver Transplantation

984

Myocardial perfusion abnormalities during low-dose dobutamine after coronary reperfusion can be demonstrated with intravenous perfluorocarbon-exposed sonicated dextrose albumin ultrasound contrast

985

Myocardial perfusion abnormality and necrosis in a patient with isolated noncompaction of the ventricular myocardium: Evaluation by myocardial perfusion SPECT and magnetic resonance imaging

986

Myocardial perfusion and fatty acid metabolism in patients with tako-tsubo-like left ventricular dysfunction

987

Myocardial perfusion and function of the systemic right ventricle in patients after atrial switch procedure for complete transposition: long-term follow-up

988

Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy

989

Myocardial Perfusion and Ventricular Function Assessed by SPECT and Gated-SPECT in End-Stage Renal Disease Patients before and after Renal Transplant

990

Myocardial perfusion and viability by positron emission tomography in infants and children with coronary abnormalities: correlation with echocardiography,coronary angiography, and histopathology

991

Myocardial perfusion assessment in patients with medium probability of coronary artery disease and no prior myocardial infarction: comparison of myocardial contrast echocardiography with 99mTc single-photon emission computed tomography

992

Myocardial perfusion before and after single routine LDL-apheresis

993

Myocardial perfusion during warm antegrade and retrograde cardioplegia: a contrast echo study

994

Myocardial perfusion grade and survival after percutaneous transluminal coronary angioplasty in patients with cardiogenic shock

995

Myocardial Perfusion Imaging and Multidetector Computed Tomographic Coronary Angiography: Appropriate for All Patients With Suspected Coronary Artery Disease?

996

Myocardial Perfusion Imaging During Adenosine-Induced Coronary Hyperemia

997

Myocardial perfusion imaging findings and the role of adenosine in the warm-up angina phenomenon

998

Myocardial perfusion imaging following percutaneous coronary intervention: the importance of restenosis, disease progression, and directed reintervention Review Article

999

Myocardial Perfusion Imaging Study of CO2-Induced Panic Attack

1000

Myocardial perfusion imaging with technetium-99m sestamibi in patients with cocaine-associated chest Pain

بازگشت